All News and Events
All News and Events for the Atlas of Variant Effects Alliance
Latest Events
25 March 2026
Event jointly organized by: AVE and St Vincent's Institute of Medical ResearchLatest News
13 July 2026
Recently, the Variant Effect Seminar Series (VESS) marked its 100th speaker. As we look to next 100, we chat with two of its original presenters, Mafalda Dias and Jonathan Frazer. Discover how VESS has influenced their journey, their connection to the 100th speaker, Ezequiel Galpern, and what’s next for them.6 July 2026
As the Variant Effects Seminar Series marks its 100th speaker, two long-standing members of the organizing team are stepping back. We caught up with them to find out about their time on the committee and what’s coming next for them.25 June 2026
For Rebeca Olvera León, the Mutational Scanning Symposium is becoming something of a habit. This year marked her fourth consecutive MSS, although her first as a PhD student. We caught up with her after the MSS 2027 announcement to get her insights into the most recent meeting and find out what she is excited for in 2027.Latest Podcast Episodes
10 July 2026
MAVEs are becoming mainstream. But what is driving their rise in popularity and who is behind their design? In this episode, we explain how new multiplexed assay technologies, like variant abundance by massively parallel sequencing (VAMP-seq), can measure how genetic variants impact protein abundance.
28 January 2026
How can different molecular measurements enhance our understanding of membrane proteins and the genetic diseases caused by their dysfunction? In this episode, we explain how membrane proteins relay environmental information to cells, focusing on channels that gate ions and molecules.
17 December 2025
How can we use genomic technologies to tackle blood diseases? In this episode, we explain the role of genetic variants in blood disorders and how genomics approaches, such as gene editing can help cure these diseases.
Latest Seminars
1 September 2026
Kortni is a PhD candidate in the Nguyen Ba Lab at the University of Toronto, Canada, where she utilizes deep mutational scanning to map how genetic variants alter protein function and drive rare genetic diseases. Her research focuses on rare disease genes and understanding how sequence variation influences transcription factor binding specificity. She uses Tiled-Region Exchange (T-REx) Mutagenesis, a novel high-throughput approach recently published by her and her lab, to systematically generate and study genetic variation at scale, using yeast as...more1 September 2026
Sergio is a computational biologist and biochemist passionate about building statistical and machine learning solutions to engineer living systems and advance biotechnology. My work focuses on developing novel computational approaches for functional protein engineering, with an emphasis on AI-driven enzyme design. I am currently pursuing a PhD at the University of Cambridge and the Wellcome Sanger Institute, working closely with Harvard Medical School.
4 August 2026
Sarah Gurev is a FutureHouse AI-for-Science Independent Postdoctoral Fellow, co-advised by Sergey Ovchinnikov and Aaron Schmidt. She recently completed her PhD in Electrical Engineering and Computer Science at MIT in Debora Marks lab. She develops machine learning models to address unmet needs in virology and immunology, with an emphasis on pandemic preparedness and therapeutic development. Her research spans viral evolution and function, precision-engineered vaccine design, viral-host interactions, and immune receptor modeling.